The Cochlear Limited share price is climbing on a new product approval

Is Cochlear Limited (ASX:COH) the best blue-chip on the ASX?

| More on:
australian currency

Shares in market-leading hearing implant manufacturer Cochlear Limited (ASX: COH) are up 33% over the course of 2017 and nearly 7% since June 13 2017 when the company gained U.S. FDA regulatory approval for its new Nucleus 7 Sound Processor.

FDA approval for any significant new product is always a welcome moment for medical device businesses and Cochlear is no different in this sense.

The N7 processor is said to be superior to the N6 as, inter alia, it is iPhone and iOS app compatible and its telecoil is optimised for loops. Notably, it is the competitive advantage derived from Cochlear’s new technologies that has allowed it to grow profits at consistent double-digit rates over a long period of time.

As such the stock trades on around 40x analysts’ estimates for earnings per share of $3.86 in FY 2017, which may sound expensive until you consider that FY 2018 is only days away.

For the next financial year analysts’ expect another year of double-digit growth as the company’s (recurring revenue) services businesses continues to grow, alongside its core business of selling hearing implants to new patients.

As such I described Cochlear shares as one of the best presents you could buy the kids at Christmas thanks to their real-deal long-term growth potential.

Cochlear shares continue to eviscerate the returns of other popular blue chips like Commonwealth Bank of Australia (ASX: CBA)Telstra Corporation Ltd (ASX: TLS) or even BHP Billiton Limited (ASX: BHP).

In fact just over 2017 Cochlear’s returns of nearly 35% are heading towards matching what anyone would have earned from holding BHP shares since 1999!

As a memory aid, below is a chart of the respective companies’ performance since 1999.

Chart: Cochlear share price performance versus BHP, Telstra and Commonwealth Bank (Source: Google Finance).

In investing it often pays to focus on what won’t change, rather than trying to work out what might change.

And I expect Cochlear’s tailwinds and competitive advantages will see it continue to outperform the market in the five years ahead.

At $160.20 it sells for 37x analysts’ estimates for FY 2018 and for anyone looking to build a diversified portfolio of the best quality ASX shares it should be at the top of their shopping list.

Of course Cochlear carries risks around valuation, its competitive environment and product quality, so you must look to the other high-quality blue chips of tomorrow on the ASX to diversify your risk.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of January 12th 2022

Motley Fool contributor Tom Richardson owns shares of Cochlear Ltd. You can find Tom on Twitter @tommyr345 The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

The share price of ASX infant products retailer Baby Bunting Group Ltd (ASX:BBN) has been a solid performer so far …

Read more »

woman holds sign saying 'we need change' at climate change protest

3 ASX ETFs that invest in companies fighting climate change

A new landmark report by the Intergovernmental Panel on Climate Change (IPCC) was released earlier this week. It provided a …

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest …

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos Limited (ASX: AMS) share price has been on a tear this past week, rising 15% on the back …

Read more »

asx share price competitions represented by businessmen arm wrestling
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

Online furniture retailer Temple & Webster Group Ltd (ASX: TPW) had a breakout year in 2020, moving from relative obscurity …

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

Shares in ASX healthcare company Polynovo Limited (ASX: PNV) almost doubled in price last year. And, despite a shaky start …

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

Investing in other geographic markets has become a popular way to diversify a portfolio. The risks associated with being exposed …

Read more »

person reading news on mobile phone
⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

Despite the News Corporation (ASX: NWS) share price getting a 31% bump between November last year and today, News Corp …

Read more »